This 5-day workshop now in its 12th year, brings together 20-25 senior fellows from the leading medical oncology, pediatric oncology, surgical oncology, radiation oncology, and surgical subspecialty fellowships in the United States.
The course is organized and directed by Co-Directors, Dr. Nora Disis, Associate Dean for Translational Health Sciences and Director of the Institute for Translational Health at the University of Washington; Dr Stacey Berg, Professor of Pediatrics and Medical Ethics at the Baylor College of Medicine, and Dr. Keith Flaherty, Director of Developmental Therapeutics at MGH/Harvard. Joining them is a faculty of recognized leaders in the areas of tumor biology, molecular oncology, product and assay development, clinical trial design, and translational oncology from major teaching institutions, NCI and industry.
The program addresses current and evolving new translational technologies used in cancer research including gene array, proteomics and analysis of genetic polymorphisms in the context of human disease. Additional topics covered overview important growth regulatory pathways in cancer, identification of therapeutic targets, basic steps in the development of a novel therapeutic or clinical assay and key regulatory aspects of product development and the conduct of human research. Throughout the course, the faculty share their own examples of translational research from their laboratories. In addition to didactic sessions the students participate in panel discussions highlighting common problems and roadblocks in translational research. Additional topics include:
- Oncogenesis and Discovery Tools
- Growth Factor Receptors
- Target Discovery and Assessment
- Genomics and Arrays
- Imaging
- Pharmacogenomics
- Preparing an Investigational New Drug Application
- From Animal Models to Novel Therapeutics
- Identifying Genes Associated with High Risk
- Stem cells
- Development of Bio-Markers and Clinical Application of Targeted Therapeutics
- Ethical and IRB issues
A unique component of the workshop is the commitment of the majority of the faculty to be in attendance during the entire course, thus, allowing the students extensive interaction with the faculty as mentors. "After dinner" talks focused on career development topics such as grant writing and creating successful oral presentations underscore the career building opportunities offered.
This program is supported by industry, the non-profit sector and individual contributions from faculty, board and alumni.
Application Deadline: February 15, 2012
Notice of Acceptance: March 15, 2012
Course Date: May 18-22, 2012
Location: Marriott Sanibel Harbor
Fort Myers, Florida
Click on a program for more information
THE MOLECULAR AND TRANSLATIONAL ONCOLOGY WORKSHOP
PHARMACOLOGIC AND MOLECULAR BASIS OF CANCER DRUG DEVELOPMENT
In addition to these programs, The Cancer Education Consortium has a strong interest in developing programs on Pharmacoeconomics, Cancer Genetics, and Cancer Survivorship.
| Workshop Pictures | ||
 |
 |
 |
 |
 |
 |